Market Research Logo

Kazakhstan Pharmaceuticals & Healthcare Q4 2018

Kazakhstan Pharmaceuticals & Healthcare Q4 2018

Key View:

Kazakhstan’s pharmaceutical market will experience double-digit growth through to 2022 and will be one of the fastestgrowing markets in the Central and Eastern Europe (CEE) region. The country is attracting greater foreign investment into itsdomestic pharmaceutical industry, with Roche and Servier the latest multinational drugmakers to commit to the market. In Addition,the state-owned SK-Pharmacy new tender favouring domestically-produced medicines in line with international standards will, inour view, lead to further investment in the domestic industry. However, given the government’s plans to expand healthcare accessand Kazakhstan’s low affordability levels, we believe opportunities will remain heavily within the generic medicines sector.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Kazakhstan Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Chimpharm
Romat
Kazakhstan Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report